ArticleSurgical case reports2025
Malignant Triton Tumor of the Ileocolic Mesentery with Neurofibromatosis Type 1: A Case Report and Literature Review.
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMalignant triton tumors (MTTs) are rare tumors histologically defined as malignant peripheral nerve sheath tumors with additional rhabdomyoblastic differentiation. MTTs occur more frequently in patients with neurofibromatosis type 1 (NF1). MTTs are most commonly found in the extremities, head and neck, and trunk; however, no cases in the mesentery have been reported. In this report, we describe a case of primary MTT of the mesentery in a patient with NF1. CASE PRESENTATION: A 29-year-old woman with NF1 visited a clinic for abdominal pain and was referred to our hospital for treatment of an abdominal tumor detected by CT. Contrast-enhanced CT showed a 20-cm irregular mass on the right side of the abdominal cavity. The mass was extensively bordered by the superior mesenteric vein (SMV), but there was no obvious distant metastasis. The patient was diagnosed with a mesenteric tumor with SMV invasion. An open biopsy was performed, and the histopathological diagnosis was MTT. The patient was discharged on the 11th day after surgery but returned to our hospital on the 17th day due to abdominal pain. The tumor had markedly enlarged on CT, and a semi-emergent tumor resection was performed. An enlarged mass was detected, but no peritoneal dissemination was observed. The tumor was in extensive contact with the SMV, but it could be dissected. A right hemicolectomy was performed, and the tumor was removed. Histopathological findings revealed a 26.5 × 17.5 × 9.5 cm tumor in the ileocolic mesentery. The dissected surface was negative for margins, with no exposed tumors. The histopathological diagnosis was MTT. Follow-up CT on postoperative day 14 revealed multiple peritoneal nodules. The patient was diagnosed with recurrent peritoneal dissemination and treated with two courses of doxorubicin and one course of pazopanib. However, she died 5 months postoperatively due to worsening peritonitis carcinomatosis.
conclusionsWe present a case of primary MTT of the mesentery. Our findings suggest that biopsy may lead to peritoneal dissemination. In patients with suspected MTT, such as those with NF1, abdominal cavity biopsy should be avoided, and diagnostic treatment should prioritize surgical resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.